Home › Funds › PAYDEN & RYGEL › DGX

PAYDEN & RYGEL position in DGX

QUEST DIAGNOSTICS INC · Health Care

PAYDEN & RYGEL reported holding 62,340 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$14.5M, representing 1.14% of its reported portfolio and ranking #38 among its reported holdings. PAYDEN & RYGEL has disclosed DGX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)62.34K sh
Reported value held$14.53M
Portfolio Weight1.14%
First reportedQ2 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How PAYDEN & RYGEL's DGX position evolved

PAYDEN & RYGEL first disclosed a stake in DGX in Q2 2025 at 93,600 shares (US$16.8M). The position peaked in Q2 2026 at 92,740 shares, worth US$19.7M. Across 6 filings, PAYDEN & RYGEL increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 62,340 shares valued at US$14.5M — a reduction of -30,400 shares quarter over quarter.. Notable position changes include a 33% trim in Q3 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 93.60K $16.81M New
Q3 2025 94.20K $17.95M Add
Q4 2025 93.40K $16.21M Reduce
Q1 2026 76.60K $15.01M Reduce
Q2 2026 92.74K $19.66M Add
Q3 2026 62.34K $14.53M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DGX and 13F data

DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 26 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.08B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$449.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DGX

All DGX fund holders →

FAQ

How long has PAYDEN & RYGEL held DGX?

PAYDEN & RYGEL has disclosed DGX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is PAYDEN & RYGEL's current position in DGX?

As of Q3 2026, PAYDEN & RYGEL holds 62.34K shares of DGX (QUEST DIAGNOSTICS INC), valued at $14.53M, representing 1.14% of its reported portfolio and ranking #38.

Has PAYDEN & RYGEL been buying or selling DGX?

In the latest 13F filing (Q3 2026), PAYDEN & RYGEL reduced its position in DGX. The position peaked in Q2 2026 at 92.74K shares.

Which other funds hold DGX?

Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.